Search research articles
Contact Us
Filters
Showing results (161-170 of 203) with videos related to
Page
of 21
Sort By:
The American Journal of Medicine
|
February 3, 2019
Clinician's Guide to the Updated ABCs of Cardiovascular Disease Prevention: A Review Part 1
Kelly Arps, Vincent A Pallazola, Rhanderson Cardoso, et al.
American Journal of Preventive Cardiology
|
December 8, 2021
Shared decision making and patient reported outcomes among adults with atherosclerotic cardiovascular disease, medical expenditure panel survey 2006-2015
Victor Okunrintemi, Javier Valero-Elizondo, Neil J Stone, et al.
Journal of the American Geriatrics Society
|
October 3, 2018
Statins for Primary Prevention in Older Adults-Moving Toward Evidence-Based Decision-Making
Sonal Singh, Susan Zieman, Alan S Go, et al.
Journal of the American Heart Association
|
November 10, 2020
Shared Decisions: A Qualitative Study on Clinician and Patient Perspectives on Statin Therapy and Statin-Associated Side Effects
Sarah T Ahmed, Julia M Akeroyd, Dhruv Mahtta, et al.
Circulation. Cardiovascular Quality and Outcomes
|
May 12, 2018
Variation in Lipid-Lowering Therapy Use in Patients With Low-Density Lipoprotein Cholesterol ≥190 mg/dL: Insights From the National Cardiovascular Data Registry-Practice Innovation and Clinical Excellence Registry
Salim S Virani, Kevin F Kennedy, Julia M Akeroyd, et al.
Circulation
|
June 5, 2002
Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve
Nalini M Rajamannan, Malayannan Subramaniam, Margaret Springett, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
August 7, 2004
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines
Scott M Grundy, James I Cleeman, C Noel Bairey Merz, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
August 7, 2004
A summary of implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines
Scott M Grundy, James I Cleeman, C Noel Bairey Merz, et al.
Circulation
|
December 28, 2018
Applicability and Cost Implications for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Based on the ODYSSEY Outcomes Trial
Salim S Virani, Julia M Akeroyd, Vijay Nambi, et al.
Journal of the American College of Cardiology
|
September 11, 2004
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
Scott M Grundy, James I Cleeman, C Noel Bairey Merz, et al.
Page
of 21
Search research articles
Search
Showing results (161-170 of 203) with videos related to
Sort By:
Page
of 21
The American Journal of Medicine
|
February 3, 2019
Clinician's Guide to the Updated ABCs of Cardiovascular Disease Prevention: A Review Part 1
Kelly Arps, Vincent A Pallazola, Rhanderson Cardoso, et al.
American Journal of Preventive Cardiology
|
December 8, 2021
Shared decision making and patient reported outcomes among adults with atherosclerotic cardiovascular disease, medical expenditure panel survey 2006-2015
Victor Okunrintemi, Javier Valero-Elizondo, Neil J Stone, et al.
Journal of the American Geriatrics Society
|
October 3, 2018
Statins for Primary Prevention in Older Adults-Moving Toward Evidence-Based Decision-Making
Sonal Singh, Susan Zieman, Alan S Go, et al.
Journal of the American Heart Association
|
November 10, 2020
Shared Decisions: A Qualitative Study on Clinician and Patient Perspectives on Statin Therapy and Statin-Associated Side Effects
Sarah T Ahmed, Julia M Akeroyd, Dhruv Mahtta, et al.
Circulation. Cardiovascular Quality and Outcomes
|
May 12, 2018
Variation in Lipid-Lowering Therapy Use in Patients With Low-Density Lipoprotein Cholesterol ≥190 mg/dL: Insights From the National Cardiovascular Data Registry-Practice Innovation and Clinical Excellence Registry
Salim S Virani, Kevin F Kennedy, Julia M Akeroyd, et al.
Circulation
|
June 5, 2002
Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve
Nalini M Rajamannan, Malayannan Subramaniam, Margaret Springett, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
August 7, 2004
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines
Scott M Grundy, James I Cleeman, C Noel Bairey Merz, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
August 7, 2004
A summary of implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines
Scott M Grundy, James I Cleeman, C Noel Bairey Merz, et al.
Circulation
|
December 28, 2018
Applicability and Cost Implications for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Based on the ODYSSEY Outcomes Trial
Salim S Virani, Julia M Akeroyd, Vijay Nambi, et al.
Journal of the American College of Cardiology
|
September 11, 2004
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
Scott M Grundy, James I Cleeman, C Noel Bairey Merz, et al.
Page
of 21